Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
Secondary-Findings-Penetrance-Policy

Learn More

Addendum: Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
Addendum-CYP2C9-VKORC1

Learn More

ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
version-3-2-Secondary-Findings

Learn More

Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG)
Postmortem-Genetic-Testing

Learn More

The designated record set for clinical genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
Designated-Record-Set

Learn More

Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
Detection-Germline-Structural-Variants

Learn More

Addendum: Preconception and prenatal testing of biologic fathers for carrier status; Carrier screening in individuals of Ashkenazi Jewish descent; Carrier screening for spinal muscular atrophy
Addendum-Three-carrier-screening

Learn More

Considerations for policymakers for improving health care through telegenetics: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
Access-to-Telegenetics

Learn More

ACMG-ASHG-NSGC Joint Response to Supreme Court Decision to Overrule Roe v Wade (2022)
Dobbs v. Jackson Final.ACMG-2022.pdf

Learn More

ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
Secondary-Findings-v3.1

Learn More

Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
Stewardship_of_genomic_data

Learn More

Focused Revision: Policy statement on folic acid and neural tube defects
s41436-021-01226-6

Learn More

Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG)
s41436-021-01247-1

Learn More

ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
41436_2021_1172_OnlinePDF-1

Learn More

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
41436_2021_1171_OnlinePDF-1

Learn More

DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG)
DNA-based-screening-and-personal-health

Learn More

DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
DNA-based screening and population health 3-16-21

Learn More

ACMG Diversity Statement
ACMG Diversity Statement

Learn More

Addendum: Statement on nutritional supplements and piracetam for children with Down syndrome
Statement-on-nutritional-supplements-and-piracetam-for-children-with-down-syndrome

Learn More

The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
The-interface-of-genomic-information-with-the-electronic-health-record

Learn More

Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)
Points to consider for reporting of germline variation in patients undergoing tumor testing

Learn More

Risk categorization for oversight of laboratory-developed tests for inherited conditions: an updated position statement of the American College of Medical Genetics and Genomics (ACMG) (update of Monaghan et al. 2013)
Risk categorization for oversight of laboratory-developed tests for inherited conditions

Learn More

Points to consider: is there evidence to support BRCA 1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)
Points to consider is there evidence to support BRCA12

Learn More

Access to reproductive options after prenatal diagnosis—patient access and physician responsibilities: an updated position statement of the American College of Medical Genetics and Genomics (ACMG)
Access to reproductive options after prenatal

Learn More

The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
The use of ACMG secondary findings recommendations for general population screening: a policy statem

Learn More

Patient re-contact after revision of genomic test results: points-to-consider—a statement of the American College of Medical Genetics and Genomics (ACMG)
Patient re-contact after revision of genomic test results: Points-to-Consider

Learn More

Standards of Professionalism
Standards of Professionalism

Learn More

Background Information and Instructions for Developing a Statement, Practice Guideline or Other Project
Background Information and Instructions for Developing a Statement, Practice Guideline or Other Proj

Learn More

Insuring patient access and affordability for treatments for rare and ultrarare diseases: a policy statement of the American College of Medical Genetics and Genomics
ACMG Statement Insuring Patient Access and Affordability for Treatments

Learn More

Considerations in healthcare reform for patients and families with genetic diseases: a statement of the American College of Medical Genetics and Genomics
Considerations in healthcare reform for patients and families with genetic diseases: a statement of

Learn More

Professional responsibilities regarding the provision, publication, and dissemination of patient phenotypes in the context of clinical genetic and genomic testing: points to consider -- a statement of the ACMG
Professional responsibilities regarding the provision,publication, and dissemination of patient phen

Learn More

Genome editing in clinical genetics: points to consider—a statement of the American College of Medical Genetics and Genomics
Genome editing in clinical genetics: points to consider -- a statement of the American Medical Genet

Learn More

Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics
Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position

Learn More

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 up

Learn More

Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics
Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the Americ

Learn More

Direct-to-consumer genetic testing: a revised position statement of the American College of Medical Genetics and Genomics
ACMG Revised Position Statement on Direct-to-Consumer Genetic Testing

Learn More

Scope of practice: a statement of the American College of Medical Genetics and Genomics (ACMG)
Scope of practice: a statement of the American College of Medical Genetics and Genomics (ACMG)

Learn More

Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics
Clinical utility of genetic and genomic services: a position statement of the American College of Me

Learn More

ACMG statement on access to reproductive options after prenatal diagnosis
ACMG Statement on Access to Reproductive Options After Prenatal Diagnosis

Learn More

Points to consider for informed consent for genome/exome sequencing
Points to Consider for Informed Consent for Genome/Exome Sequencing

Learn More

Incidental findings in clinical genomics: a clarification
Incidental Findings in Clinical Genomics: A Clarification

Learn More

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
ACMG Recommendations for reporting of incidental findings in clinical exome and genome sequencing

Learn More

ACMG position statement on prenatal/preconception expanded carrier screening
ACMG position statement on prenatal/ preconception expanded carrier screening

Learn More

Technical report: ethical and policy issues in genetic testing and screening of children
Technical report: ethical and policy issues in genetic testing and screening of children

Learn More

ACMG Policy Statement: Risk categorization for oversight of laboratory-developed tests for inherited conditions (see South et al. 2020 for update)
Risk categorization for oversight of laboratory-developed tests for inherited conditions

Learn More

Points to consider in the clinical application of genomic sequencing
Points to Consider in the Clinical Application of Genomic Sequencing

Learn More

American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants (see Riggs et al. 2020 for update)
American College of Medical Genetics and Genomics standards and guidelines for interpretation and re

Learn More

Policy statement on folic acid and neural tube defects
Folic Acid and Neutral Tube Defects

Learn More

Emergency preparedness for newborn screening and genetic services
Emergency Preparedness for Newborn Screening and Genetic Services

Learn More

Conflict of Interest
Conflict of Interest

Learn More

Position Statement on Importance of Residual Newborn Screening Dried Blood Spots
Position Statement on Importance of Residual Newborn Screening Dried Blood Spots

Learn More

ACMG Statement on Direct-to-Consumer Genetic Testing (retired)
ACMG Statement on Direct-to-Consumer Genetic Testing

Learn More

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin (retired)
Pharmacogenetic Testing of CYP2C9 and VKORC1alleles for Warfarin

Learn More

A rapid ACCE1 review of CYP2C9 and VKORC1 allele testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding
A Rapid ACCE1 Review of CYP2C9 and VKORC1 Allele Testingto Inform Warfarin Dosing in Adults at Elev

Learn More

Newborn screening: toward a uniform screening panel and system (main report)
Newborn Screening: Toward a Uniform Screening Panel and System

Learn More

Genetics and managed care: Policy statement of the American College of Medical Genetics
Genetics and Managed Care

Learn More

Points to consider in preventing unfair discrimination based on genetic disease risk: a position statement of the American College of Medical Genetics
Points to Consider in Preventing Unfair Discrimination Based on Genetic Disease Risk: A Position Sta

Learn More

Laboratory standards and guidelines for population based cystic fibrosis carrier screening (see Deignan et al. 2020 for update)
Laboratory Standards and Guidelines for Population Based Cystic Fibrosis Carrier Screening

Learn More

Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations
FISH2: FISH Technical and Clinical Assessment of: An ACMG/ASHG Position Statement. I: Technical Cons

Learn More

Guidelines for expert witness testimony for the specialty of medical genetics
Guidelines for Expert Witness Testimony for the Specialty of Medical Genetics

Learn More

Tandem mass spectrometry in newborn screening
Tandem Mass Spectrometry in Newborn Screening

Learn More

Genetic testing in adoption (ACMG/ASHG)
Genetic Testing in Adoption (ACMG/ASHG)

Learn More

Statement of the American College of Medical Genetics on universal newborn hearing screening
Statement on Universal Newborn Hearing Screening

Learn More

American College of Medical Genetics position statement on gene patents and accessibility of gene testing
Position Statement on Gene Patents & Accessibility of Gene Testing

Learn More

Duty to re-contact
Duty to Re-Contact

Learn More

Statement on nutritional supplements and piracetam for children with Down syndrome (retired)
Statement on Nutritional Supplements & Piracetam for Children with Down Syndrome

Learn More

Statement on storage and use of genetic materials (retired)
Statement on Storage & Use of Genetic Materials

Learn More

Statement on use of apolipoprotein E testing for Alzheimer disease
Consensus Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

Learn More